ID: MRFR/Pharma/3979-CR | February 2021 | Region: Global | 151 pages
The CAGR for the Sleeping Bruxism Treatment Market is 6.7% in the forecast period. The Sleeping Bruxism Treatment Market valuation will reach a mark of USD 638.2 Million in 2023. The Market shows strong trends of growth in the forecast period. In this Market report, all the details of the Market forecast are discussed.
The condition of Sleep Bruxism is one where the patient grinds his teeth during sleep. Bruxism is something that happens during the day. However, it also happens involuntarily in sleep too. The condition of sleep bruxism is more serious because the patient is not aware at that time. The patient applies a lot of force on his teeth and jaw during such episodes. This inflicts a lot of damage to the teeth and jaw. The patient cannot control the force he puts on his teeth and jaw. Therefore, it becomes necessary to treat the symptoms of sleep bruxism. The Sleeping Bruxism Treatment Industry deals with the various treatment and care approaches for sleep bruxism recovery.
People who use tobacco, alcohol, or other intoxicating substances are more prone to Sleeping Bruxism. The people who take antidepressants also go through such conditions. People who smoke cigarettes and regularly drink caffeine are also prone to sleeping bruxism. Since a lot of people consume such substances, sleep bruxism is pretty common today. Therefore, there is a huge opportunity for the Sleeping Bruxism Treatment Industry to step up.
The instances of sleep bruxism are not persistent throughout the night for the patients. Instead, people suffer episodes of Sleep Bruxism at times. However, the force of grinding is so high that the person suffers much damage within a few minutes.
COVID 19 Analysis
The COVID 19 pandemic and bruxism, in general, are highly connected. The COVID 19 pandemic causes a lot of stress for different people. The study of people’s behavior shows that instances of stress as well as factors of stress have increased for the population. This is a direct impact of the socioeconomic disruption caused by the pandemic. People have turned towards antidepressants and sleeping pills to induce sound sleep. However, such substances can also result in sleeping bruxism.
Therefore, instances of sleeping bruxism have increased over the span of the pandemic. This creates a window of growth for the Sleeping Bruxism Treatment Market. However, the highest focus of the healthcare industry has been on treating COVID 19 infections. This means that sleeping bruxism takes a secondary place as compared to COVID 19 treatment.
Therefore, the growth rate of the Sleeping Bruxism Treatment Industry has been moderate over the pandemic. However, the post-pandemic era seems promising for Sleeping Bruxism Treatment Market Growth.
Key drivers of the market
As discussed earlier, the increased prevalence of sleep bruxism on a global scale is a major driver of the Market. According to an NCBI scientific study, the prevalence of Sleeping Bruxism borders on 12.5 percent. This figure is increasing day by day due to the increased usage of psychoactive substances and antidepressants. The prevalence increases the scope of application for the Market. Another driver of the market is the increase in stress among people. In the busy pace of life and under a cloud of the pandemic, the Market has an opening for Sleeping Bruxism Treatment Market Growth.
The COVID 19 pandemic and the post-pandemic phase is a period of significant opportunity for the Sleeping Bruxism Treatment Industry Size. The increased level of stress due to the COVID 19 pandemic has created an opportunity for Sleeping Bruxism treatment drugs. With the increased sale of the treatment drugs, the Sleeping Bruxism Treatment Market Size will increase by itself. However, there are some market restraints on which it has to function.
The Sleeping Bruxism Treatment Market has certain restraints, such as the unavailability of treatment options. There is a lack of research and development in the Market that hinders its Sleeping Bruxism Treatment Industry Growth. The Market, therefore, has to focus more on developing more advanced treatment options. The key players of the Sleeping Bruxism Treatment Industry have to contribute to this for the future. Without research and development, the Market Growth will stagnate.
The High cost of custom-fit night guards is also a market challenge that hiders the growth of the Sleeping Bruxism Treatment Market. Until and unless the cost of night guards reduces and aids the Sleeping Bruxism Treatment drugs in the application, the Sleeping Bruxism Treatment Industry will not see wholesome growth. The present effort is towards decreasing the impact of the high cost associated with night guards and sleeping bruxism treatment.
Cumulative Growth Analysis
Overall, the Sleeping Bruxism Treatment Industry Forecast shows that the Sleeping Bruxism Treatment Market Value will grow at a healthy rate of nearly 7 percent in the forecast period. The Market Value increases in the forecast period and will reach a valuation of nearly a trillion. The many drivers, opportunities, and Market trends will support the growth of the Sleeping Bruxism Treatment Market during the Market forecast period.
According to the Sleeping Bruxism Treatment Market Analysis, there are different segments of the Healthcare Consulting Services Market. The Sleeping Bruxism Treatment Market Share disperses over different segments according to type, diagnosis, treatment type, etc.
By type- By type, the treatment divides into primary bruxism and secondary bruxism.
By diagnosis- By diagnosis, the Market divides into clinical examination and polysomnography.
By treatment- By treatment, the Market Share divides into dental approaches and treatment drugs.
By cause – By cause, the Market the obstructive sleep apnea, GERD, malocclusion, and sleep paralysis.
By patient type- The Market divides into pediatric and adult based on patient classification.
By regions, the Sleeping Bruxism Treatment Market disperses over major regional markets of North America, Europe, and the Asia Pacific. According to the Sleeping Bruxism Treatment Market Outlook, the majority of the Market share belongs to the North American region. The Market trends point towards the European region becoming the fastest growing regional market for Sleeping Bruxism Treatment by 2028. The regional markets of the Asia Pacific and the Middle East will also register considerable growth due to the high population. However, the African regional market will show the lowest growth trend due to a lack of health awareness in the region.
The Sleeping Bruxism Treatment market has different competitors who belong to different countries, the primary companies that dot the competitive landscape of the market are-
These competitors of the Sleeping Bruxism Treatment Industry belong to different nationalities and contribute to the market in various ways.
Apart from this, the leading competitors of the market undertake mergers, acquisitions, and deals to improve their standing in the market. This profits the market in terms of Sleeping Bruxism Treatment Market trends of growth.
The Sleeping Bruxism Treatment Market Outlook or overview is as follows:
This report focuses on the Sleeping Bruxism Treatment Industry and its trends. It highlights the key drivers, significant opportunities for growth, and presents market challenges of the Sleeping Bruxism Treatment Industry. Thirdly, it discusses the segmentation of the Sleeping Bruxism Treatment Industry over various benchmarks and segments. Additionally, the Sleeping Bruxism Treatment Market Outlook sheds more light on the competitive landscape and recent developments of the market. It creates an overall reading of the Sleeping Bruxism Treatment Industry Forecast for the readers.
|Market Size||USD 638.22 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Diagnosis, Treatment Type, Patient Type, End User and Region|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Ivoclar Vivadent AG, Ipsen Biopharmaceuticals, Inc., Merz Pharma GmbH & Co. KGaA, Carestream Dental, Akervall Technologies Inc., PLANMECA OY, Randmark Dental Products, LLC, S4S Dental Laboratory, Patterson Dental Supply, Inc., Henry Schein, Inc., and Pfizer Inc.|
|Key Market Opportunities||Untapped Markets Of The Asia-Pacific Region|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Sleeping bruxism treatment market projected to grow at approximately 6.7% CAGR during the assessment period (2020-2027).
The valuation of the sleeping bruxism treatment market is estimated to increase to USD 638.2 MN by the end of 2023.
Increasing prevalence of the disorder and growing funding & healthcare insurance coverage, are major tailwinds pushing the growth of the sleeping bruxism treatment market.
North America holds the largest share in the sleeping bruxism treatment market, followed by Europe and the Asia Pacific, respectively.
Ipsen Biopharmaceuticals, Inc., Pfizer Inc., Ivoclar Vivadent AG, Henry Schein, Inc., Merz Pharma GmbH & Co. KGaA, Carestream Dental, Patterson Dental Supply, Inc., S4S Dental Laboratory, Akervall Technologies Inc., PLANMECA OY, and Randmark Dental Products, LLC, are some of the top players operating in the global sleeping bruxism treatment market.
Sleeping Bruxism Market: Competitive Landscape
The sleeping bruxism treatment market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products, to survive and succeed in an intensely competitive market environment.
The growth of the market vendors is dependent on the market conditions, government support, and industry development. Thus, the vendors should focus on expanding geographically and improving their products. They primarily focus on the development of novel products. Although the international players are dominating the market, regional and foreign players with small market shares also have a presence. The international players may strengthen their presence worldwide through acquisitions during the forecast period. It has also been forecast that improvement of the global economic scenario combined with efforts to enhance infrastructure in emerging nations, is fueling the market growth, thereby making it an ideal time to new products and increase the global market share.
The vendors with better technical and financial resources can develop innovative products. Therefore, vendors must develop new technologies and stay abreast of emerging technologies that could affect the continuing competitiveness of their treatment lines in the market.
Ipsen Biopharmaceuticals, Inc has a vast product portfolio in the sleeping bruxism treatment industry. The company also has a wide geographic presence as it operates in various countries across the world. They have a significant presence in North America, Europe, the Middle East & Africa, with commercial, manufacturing, and research facilities in more than one dozen countries.
The top three manufacturers in the market are inclusive of:
Randmark Dental Products, LLC has 70 years of experience in clinical dentistry and occlusal therapy. The company's line of business includes the manufacturing of dental night guards. The company’s NiteBite is patented and is an FDA-cleared device that functions within the patient's freeway space. The strengths of the company are inclusive of patented & FDA cleared devices and skilled workforce. The company is focused on product enhancements to enhance its customer base in the United States.
S4S Dental Laboratory provides dental solutions such as occlusal splints that aids in the treatment of bruxism (facial pain, migraines, clenching, tooth wear, and TMJ dysfunction) and anti-snoring and sleep apnoea devices. The company complies with the requirements of DAMAS (Dental Appliance Manufacturers Audit Scheme) to enhance its quality management system. The company is focused on developing a wide range of products for dental and sleep-related breathing disorders. Moreover, the company’s focus is on building partnerships to provide holistic solutions.
Ipsen Biopharmaceuticals, Inc. provides treatment for oncology, neuroscience, and rare diseases. It has two operating segments, namely, specialty care and consumer healthcare. The company focuses on developing innovative solutions to fulfill the customers’ needs. Innovative drugs and skilled workforce followed by a Strong R&D are the major factors strengthening the presence of the company in the market.